Canada: Medicaments Containing Hormones Market 2024

Medicaments Containing Hormones Market Size in Canada

The Canadian medicaments containing hormones market shrank to $X in 2023, declining by X% against the previous year. In general, consumption, however, enjoyed a perceptible expansion. Over the period under review, the market hit record highs at $X in 2016; however, from 2017 to 2023, consumption remained at a lower figure.

Medicaments Containing Hormones Production in Canada

In value terms, medicaments containing hormones production declined to $X in 2023 estimated in export price. Overall, production, however, enjoyed buoyant growth. The pace of growth was the most pronounced in 2015 when the production volume increased by X%. Over the period under review, production reached the maximum level at $X in 2016; however, from 2017 to 2023, production failed to regain momentum.

Medicaments Containing Hormones Exports

Exports from Canada

In 2023, after five years of decline, there was significant growth in shipments abroad of medicaments containing hormones but not antibiotics, when their volume increased by X% to X tons. Over the period under review, exports continue to indicate a strong increase. The exports peaked at X tons in 2017; however, from 2018 to 2023, the exports remained at a lower figure.

In value terms, medicaments containing hormones exports surged to $X in 2023. In general, exports recorded resilient growth. Over the period under review, the exports attained the peak figure at $X in 2018; however, from 2019 to 2023, the exports stood at a somewhat lower figure.

Exports by Country

Ireland (X tons) was the main destination for medicaments containing hormones exports from Canada, accounting for a X% share of total exports. It was followed by Italy (X tons), with a X% share of total exports.

From 2012 to 2023, the average annual growth rate of volume to Ireland stood at X%. Exports to the other major destinations recorded the following average annual rates of exports growth: Italy (X% per year) and the United States (X% per year).

In value terms, Ireland ($X) emerged as the key foreign market for medicaments containing hormones but not antibiotics exports from Canada, comprising X% of total exports. The second position in the ranking was taken by the United States ($X), with a X% share of total exports.

From 2012 to 2023, the average annual rate of growth in terms of value to Ireland amounted to X%. Exports to the other major destinations recorded the following average annual rates of exports growth: the United States (X% per year) and Italy (X% per year).

Export Prices by Country

In 2023, the average medicaments containing hormones export price amounted to $X per ton, shrinking by X% against the previous year. Over the period under review, the export price saw a abrupt slump. The growth pace was the most rapid in 2022 an increase of X% against the previous year. As a result, the export price attained the peak level of $X per ton, and then fell sharply in the following year.

There were significant differences in the average prices for the major export markets. In 2023, amid the top suppliers, the country with the highest price was the United States ($X per ton), while the average price for exports to Italy ($X per ton) was amongst the lowest.

From 2012 to 2023, the most notable rate of growth in terms of prices was recorded for supplies to Israel (X%), while the prices for the other major destinations experienced mixed trend patterns.

Medicaments Containing Hormones Imports

Imports into Canada

Medicaments containing hormones imports into Canada soared to X tons in 2023, with an increase of X% compared with 2022. Over the period under review, imports saw prominent growth. The pace of growth appeared the most rapid in 2021 with an increase of X% against the previous year. As a result, imports reached the peak of X tons. From 2022 to 2023, the growth of imports remained at a lower figure.

In value terms, medicaments containing hormones imports skyrocketed to $X in 2023. In general, imports posted significant growth. The pace of growth appeared the most rapid in 2021 with an increase of X%. As a result, imports attained the peak of $X. From 2022 to 2023, the growth of imports failed to regain momentum.

Imports by Country

In 2023, Ireland (X tons) constituted the largest supplier of medicaments containing hormones to Canada, accounting for a X% share of total imports. Moreover, medicaments containing hormones imports from Ireland exceeded the figures recorded by the second-largest supplier, the United States (X tons), twofold. China (X tons) ranked third in terms of total imports with a X% share.

From 2012 to 2023, the average annual growth rate of volume from Ireland totaled X%. The remaining supplying countries recorded the following average annual rates of imports growth: the United States (X% per year) and China (X% per year).

In value terms, Ireland ($X), the United States ($X) and China ($X) were the largest medicaments containing hormones suppliers to Canada, together accounting for X% of total imports.

Ireland, with a CAGR of X%, saw the highest growth rate of the value of imports, among the main suppliers over the period under review, while purchases for the other leaders experienced more modest paces of growth.

Import Prices by Country

The average medicaments containing hormones import price stood at $X per ton in 2023, shrinking by X% against the previous year. Over the period under review, the import price, however, showed a resilient increase. The pace of growth appeared the most rapid in 2021 an increase of X% against the previous year. The import price peaked at $X per ton in 2022, and then contracted dramatically in the following year.

There were significant differences in the average prices amongst the major supplying countries. In 2023, amid the top importers, the country with the highest price was the UK ($X per ton), while the price for China ($X per ton) was amongst the lowest.

From 2012 to 2023, the most notable rate of growth in terms of prices was attained by Ireland (X%), while the prices for the other major suppliers experienced more modest paces of growth.

Source: IndexBox Platform